Senior insider sale
Chief Financial Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.20M
39.29K shares
What this filing means
SETIA VISHWAS plans to sell 39.29K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001974158-26-000066
Officer· Chief Financial Officer
Since Feb 2026
39.29K
Shares to sell
$1.20M
Approx. market value
36.37K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vested RSU
N/A
3/4/2025
36.37KTotal acquired36.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2025 | Vested RSU N/A | 36.37K | — |
| Total | 36.37K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
116.00
Market value
$3.2K
4/16/2026
—Completed
Units to sell
2.81K
Market value
$75.4K
4/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
36.37K
Market value
$1.12M
5/4/2026
Total
Units
39.29K
Value
$1.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 116.00 | $3.2K | — | Completed |
4/15/2026 | 2.81K | $75.4K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 36.37K | $1.12M | Nasdaq | Planned |
| Total | 39.29K | $1.20M | ||